| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |